DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

Wei Meng,Guohua Zhao

申请号：

US15123791

公开号：

US20170015653A1

申请日:

2015.03.05

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/